<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1904431606345510&amp;ev=PageView&amp;noscript=1">

Debra Zalvan

Debra Zalvan is UbiCare's Executive VP of Marketing. She focuses on expanding our business scope, bringing UbiCare to new markets and honing our messaging. She provides project governance for UbiCare’s new projects, as well as our work with the Department of Defense.
Find me on:

Recent Posts

How Digital Healthcare Technology Improves Health Literacy and Outcomes Through Patient Engagement

Posted by Debra Zalvan on May 11, 2021 5:43:09 AM

In just 68 seconds, our new video demonstrates how digital healthcare technology improves health literacy and healthcare outcomes by guiding a patient's daily actions through text messaging, email and app.

Read More

Topics: Patient Engagement, Patient Experience, Healthcare Technology, health literacy, ASC

Ambulatory Surgery Centers Succeed by Continuously Engaging Patients

Posted by Debra Zalvan on Mar 10, 2021 4:58:14 PM

A powerful tool and essential addition to the patient-centered digital ecosystem of Ambulatory Surgery Centers (ASCs) is a patient engagement platform.

Clients that have used the SmarteXp® platform to support outpatient joint replacement surgeries tell us that virtual patient engagement is an important factor in their success.  The platform and proven, evidence-based content ensures that patients remain engaged throughout their health journey, beyond the face-to-face interactions in pre- and post-op appointments.

Read More

Virtual Patient Engagement: Critical for ASCs Competing for TJRs

Posted by Debra Zalvan on Mar 10, 2021 10:34:11 AM

How does an Ambulatory Surgery Center manage the continuum of care and associated risks without the traditional infrastructure of hospitals, while also keeping costs under control?

Read More

Topics: joint replacement, ASC

New CMS Rules Represent Tremendous Opportunity for ASCs

Posted by Debra Zalvan on Mar 9, 2021 6:04:35 PM

In 2021, the U.S. Centers for Medicare & Medicaid Services (CMS) authorized payment to ambulatory surgery centers (ASCs) for outpatient hip replacement surgeries, adding to the outpatient knee replacement surgeries authorized the previous year. 

The size and projected market growth for outpatient total knee and hip replacement surgeries represent tremendous opportunity—with a projected $13.5B in total joint replacement (TJR) business for ASCs, and nearly half of all joint replacement surgeries expected to move to outpatient centers by 2026.

But while the market and opportunity for ASCs is enormous, so are the challenges, as:

Read More

Topics: CMS, joint replacement, ASC